We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYNO
51
DELISTED
Cynosure, Inc. Class A
CYNO
| $2.1M | 0.3% |
47,702
-46,533
| -49% | -$1.82M |
|
|
INFI
52
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.1M | 0.3% |
399,320
+385,957
| +2,888% | +$2.36M |
|
|
HMSY
53
DELISTED
HMS Holdings Corp.
HMSY
| $2.1M | 0.3% |
+146,385
| New | +$1.82M |
|
|
ATRI
54
DELISTED
Atrion Corp
ATRI
| $2.1M | 0.3% |
5,302
-10,292
| -66% | -$3.89M |
|
|
LDL
55
DELISTED
Lydall, Inc.
LDL
| $2.09M | 0.3% |
+64,282
| New | +$1.89M |
|
56
Skywest
SKYW
$4.11B
| $2.09M | 0.3% |
104,504
-74,435
| -42% | -$1.26M |
|
57
ICU Medical
ICUI
$3.93B
| $2.09M | 0.3% |
20,039
+1,170
| +6% | +$112K |
|
58
V2X
VVX
$2.62B
| $2.08M | 0.3% |
91,463
-56,555
| -38% | -$1.12M |
|
59
Asbury Automotive
ABG
$4.19B
| $2.06M | 0.3% |
34,508
+13,575
| +65% | +$739K |
|
60
Quad
QUAD
$430M
| $2.06M | 0.3% |
159,320
-162,984
| -51% | -$1.76M |
|
61
Marcus & Millichap
MMI
$1.15B
| $2.04M | 0.29% |
+80,285
| New | +$1.88M |
|
62
Delek US
DK
$3.87B
| $2.04M | 0.29% |
133,640
-81,360
| -38% | -$1.31M |
|
|
BKS
63
DELISTED
Barnes & Noble
BKS
| $2.04M | 0.29% |
164,617
-162,723
| -50% | -$1.59M |
|
|
FLOW
64
DELISTED
SPX FLOW, Inc.
FLOW
| $2.03M | 0.29% |
+80,961
| New | +$1.77M |
|
|
SEMG
65
DELISTED
SEMGROUP CORPORATION
SEMG
| $2.03M | 0.29% |
90,495
+28,934
| +47% | +$597K |
|
66
Metallus
MTUS
$873M
| $2.02M | 0.29% |
222,446
+27,105
| +14% | +$198K |
|
|
VG
67
DELISTED
Vonage Holdings Corporation
VG
| $2.01M | 0.29% |
440,506
+424,760
| +2,698% | +$2.1M |
|
68
Belden
BDC
$4B
| $2M | 0.29% |
32,572
-22,688
| -41% | -$1.12M |
|
69
PBF Energy
PBF
$7.29B
| $2M | 0.29% |
+60,105
| New | +$1.92M |
|
70
Regal Rexnord
RRX
$14.2B
| $1.99M | 0.29% |
31,554
-75,031
| -70% | -$4.2M |
|
71
Tenet Healthcare
THC
$20.1B
| $1.98M | 0.29% |
+68,506
| New | +$1.78M |
|
|
INWK
72
DELISTED
InnerWorkings, Inc.
INWK
| $1.98M | 0.29% |
+249,342
| New | +$1.75M |
|
|
ACET
73
DELISTED
Aceto Corp
ACET
| $1.97M | 0.28% |
+83,794
| New | +$1.85M |
|
|
MENT
74
DELISTED
Mentor Graphics Corp
MENT
| $1.95M | 0.28% |
+95,775
| New | +$1.75M |
|
75
Foster
FSTR
$443M
| $1.93M | 0.28% |
105,987
+87,285
| +467% | +$1.16M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.